| Name | HBV-IN-19 TFA |
|---|
| Description | HBV-IN-19 TFA inhibits hepatitis B virus (HBV) infection. Inhibiting HBsAg secretion and/or production is a strategy for the treatment of HBV infection, including chronic HBV infection[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C26H31F3N2O8 |
|---|---|
| Molecular Weight | 556.53 |